| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Jian-Hui Zhu, Craig Horbinski, Fengli Guo, Simon Watkins, Yasuo Uchiyama, Charleen T Ch. Regulation of autophagy by extracellular signal-regulated protein kinases during 1-methyl-4-phenylpyridinium-induced cell death. The American journal of pathology. vol 170. issue 1. 2007-02-21. PMID:17200184. |
likewise, in primary midbrain dopaminergic neurons, mpp+ elicited increased av content, which was reversed by inhibition of mitogen-activated protein kinase/extracellular signal-regulated protein kinase kinase but not pi3k. |
2007-02-21 |
2023-08-12 |
Not clear |
| Gi Hoon Son, Sooyoung Chung, Dongho Geum, Sang Soo Kang, Wan Sung Choi, Kyungjin Kim, Sukwoo Cho. Hyperactivity and alteration of the midbrain dopaminergic system in maternally stressed male mice offspring. Biochemical and biophysical research communications. vol 352. issue 3. 2007-02-12. PMID:17150178. |
hyperactivity and alteration of the midbrain dopaminergic system in maternally stressed male mice offspring. |
2007-02-12 |
2023-08-12 |
mouse |
| Björn Schilström, Vladimir B Ivanov, Charlotte Wiker, Torgny H Svensso. Galantamine enhances dopaminergic neurotransmission in vivo via allosteric potentiation of nicotinic acetylcholine receptors. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. vol 32. issue 1. 2007-02-09. PMID:16641937. |
we have previously shown that nicotine, through stimulation of nachrs in the ventral tegmental area (vta), activates midbrain dopamine neurons and, hence, potentiation of these receptors could be an additional mechanism by which galantamine can activate dopaminergic pathways. |
2007-02-09 |
2023-08-12 |
rat |
| Heli Tuppurainen, Jyrki T Kuikka, Mikko P Laakso, Heimo Viinamäki, Minna Husso, Jari Tiihone. Midbrain dopamine D2/3 receptor binding in schizophrenia. European archives of psychiatry and clinical neuroscience. vol 256. issue 6. 2007-02-08. PMID:16783502. |
several studies suggest that dysregulation of dopaminergic transmission in the midbrain and thalamus may contribute to the symptomatology of schizophrenia. |
2007-02-08 |
2023-08-12 |
Not clear |
| Heli Tuppurainen, Jyrki T Kuikka, Mikko P Laakso, Heimo Viinamäki, Minna Husso, Jari Tiihone. Midbrain dopamine D2/3 receptor binding in schizophrenia. European archives of psychiatry and clinical neuroscience. vol 256. issue 6. 2007-02-08. PMID:16783502. |
these observations implicate altered dopaminergic activity in the midbrain of schizophrenic patients. |
2007-02-08 |
2023-08-12 |
Not clear |
| Kari Hänninen, Heikki Katila, Sami Anttila, Riikka Rontu, Julius Maaskola, Mikko Hurme, Terho Lehtimäk. Epidermal growth factor a61g polymorphism is associated with the age of onset of schizophrenia in male patients. Journal of psychiatric research. vol 41. issue 1-2. 2007-02-06. PMID:16115648. |
epidermal growth factor (egf) gene polymorphism has an impact on egf production in mononuclear cells, and egf seems to affect the development of midbrain dopaminergic neurons. |
2007-02-06 |
2023-08-12 |
human |
| Sabrina M Tom, Craig R Fox, Christopher Trepel, Russell A Poldrac. The neural basis of loss aversion in decision-making under risk. Science (New York, N.Y.). vol 315. issue 5811. 2007-02-06. PMID:17255512. |
a broad set of areas (including midbrain dopaminergic regions and their targets) showed increasing activity as potential gains increased. |
2007-02-06 |
2023-08-12 |
Not clear |
| P-S Chen, G-S Peng, G Li, S Yang, X Wu, C-C Wang, B Wilson, R-B Lu, P-W Gean, D-M Chuang, J-S Hon. Valproate protects dopaminergic neurons in midbrain neuron/glia cultures by stimulating the release of neurotrophic factors from astrocytes. Molecular psychiatry. vol 11. issue 12. 2007-02-02. PMID:16969367. |
valproate protects dopaminergic neurons in midbrain neuron/glia cultures by stimulating the release of neurotrophic factors from astrocytes. |
2007-02-02 |
2023-08-12 |
rat |
| P-S Chen, G-S Peng, G Li, S Yang, X Wu, C-C Wang, B Wilson, R-B Lu, P-W Gean, D-M Chuang, J-S Hon. Valproate protects dopaminergic neurons in midbrain neuron/glia cultures by stimulating the release of neurotrophic factors from astrocytes. Molecular psychiatry. vol 11. issue 12. 2007-02-02. PMID:16969367. |
increasing reports demonstrate that vpa has neurotrophic effects in diverse cell types including midbrain dopaminergic (da) neurons. |
2007-02-02 |
2023-08-12 |
rat |
| E R Samuels, R H Hou, R W Langley, E Szabadi, C M Bradsha. Comparison of pramipexole and modafinil on arousal, autonomic, and endocrine functions in healthy volunteers. Journal of psychopharmacology (Oxford, England). vol 20. issue 6. 2007-01-26. PMID:16401653. |
the activity of the locus coeruleus is believed to be tonically enhanced by a mesocoerulear dopaminergic pathway arising from the ventral tegmental area of the midbrain. |
2007-01-26 |
2023-08-12 |
human |
| C Strazielle, V Deiss, L Naudon, R Raisman-Vozari, R Lalond. Regional brain variations of cytochrome oxidase activity and motor coordination in Girk2(Wv) (Weaver) mutant mice. Neuroscience. vol 142. issue 2. 2007-01-23. PMID:16844307. |
co activity increased in midbrain dopaminergic regions after correcting for tissue density, regions with severe depletion of tyrosine hydroxylase activity. |
2007-01-23 |
2023-08-12 |
mouse |
| L Li, Y Su, C Zhao, H Zhao, G Liu, J Wang, Q X. The role of Ret receptor tyrosine kinase in dopaminergic neuron development. Neuroscience. vol 142. issue 2. 2007-01-23. PMID:16879925. |
glial cell line-derived neurotrophic factor (gdnf) is one of the most potent trophic factors identified for promoting survival and function of dopaminergic (da) neurons in the midbrain. |
2007-01-23 |
2023-08-12 |
rat |
| Yasin Temel, Veerle Visser-Vandewalle, Süleyman Kaplan, Ramazan Kozan, Marc A R C Daemen, Arjan Blokland, Christoph Schmitz, Harry W M Steinbusc. Protection of nigral cell death by bilateral subthalamic nucleus stimulation. Brain research. vol 1120. issue 1. 2007-01-23. PMID:16999940. |
in parkinson disease (pd), the subthalamic nucleus (stn) becomes hyperactive (disinhibited), which is reported to cause excitotoxic damage to midbrain dopaminergic neurons. |
2007-01-23 |
2023-08-12 |
rat |
| Yasin Temel, Veerle Visser-Vandewalle, Süleyman Kaplan, Ramazan Kozan, Marc A R C Daemen, Arjan Blokland, Christoph Schmitz, Harry W M Steinbusc. Protection of nigral cell death by bilateral subthalamic nucleus stimulation. Brain research. vol 1120. issue 1. 2007-01-23. PMID:16999940. |
here, we examined whether silencing of the hyperactive stn by chronic bilateral deep brain stimulation (dbs) increased the survival of midbrain dopaminergic neurons in a rat model of pd. |
2007-01-23 |
2023-08-12 |
rat |
| Yasin Temel, Veerle Visser-Vandewalle, Süleyman Kaplan, Ramazan Kozan, Marc A R C Daemen, Arjan Blokland, Christoph Schmitz, Harry W M Steinbusc. Protection of nigral cell death by bilateral subthalamic nucleus stimulation. Brain research. vol 1120. issue 1. 2007-01-23. PMID:16999940. |
these data provide the first evidence in vivo that bilateral stn dbs is useful for protecting midbrain dopaminergic neurons from cell death in pd. |
2007-01-23 |
2023-08-12 |
rat |
| Kristin E Larsen, Susanna C Benn, Ilknur Ay, Ru-Ju Chian, Samuel A Celia, Mary P Remington, Michelle Bejarano, Meiqin Liu, Joshua Ross, Paul Carmillo, Dinah Sah, Kester A Phillips, David Sulzer, R Blake Pepinsky, Paul S Fishman, Robert H Brown, Jonathan W Franci. A glial cell line-derived neurotrophic factor (GDNF):tetanus toxin fragment C protein conjugate improves delivery of GDNF to spinal cord motor neurons in mice. Brain research. vol 1120. issue 1. 2007-01-23. PMID:17020749. |
treatment of cultured midbrain dopaminergic neurons with either gdnf or the conjugate similarly promoted both da neuron survival and neurite outgrowth. |
2007-01-23 |
2023-08-12 |
mouse |
| Ana Saavedra, Graça Baltazar, Emília P Duart. Interleukin-1beta mediates GDNF up-regulation upon dopaminergic injury in ventral midbrain cell cultures. Neurobiology of disease. vol 25. issue 1. 2007-01-23. PMID:17027275. |
interleukin-1beta mediates gdnf up-regulation upon dopaminergic injury in ventral midbrain cell cultures. |
2007-01-23 |
2023-08-12 |
Not clear |
| Peter Redgrave, Kevin Gurne. The short-latency dopamine signal: a role in discovering novel actions? Nature reviews. Neuroscience. vol 7. issue 12. 2007-01-23. PMID:17115078. |
it maintains that midbrain dopaminergic neurons signal the occurrence of unpredicted reward, which is used in appetitive learning to reinforce existing actions that most often lead to reward. |
2007-01-23 |
2023-08-12 |
Not clear |
| Markus Kipp, Serkan Karakaya, Justyna Pawlak, Gilda Araujo-Wright, Susanne Arnold, Cordian Beye. Estrogen and the development and protection of nigrostriatal dopaminergic neurons: concerted action of a multitude of signals, protective molecules, and growth factors. Frontiers in neuroendocrinology. vol 27. issue 4. 2007-01-17. PMID:16949139. |
the nigrostriatal dopamine system comprises the dopaminergic neurons located in the ventral midbrain, their axonal connections to the forebrain, and their direct cellular target cells in the striatal complex, i.e. |
2007-01-17 |
2023-08-12 |
Not clear |
| Nijee Sharma, Katrina A Brandis, Sara K Herrera, Brandon E Johnson, Tulaza Vaidya, Ruja Shrestha, Shubhik K Debburma. alpha-Synuclein budding yeast model: toxicity enhanced by impaired proteasome and oxidative stress. Journal of molecular neuroscience : MN. vol 28. issue 2. 2007-01-09. PMID:16679556. |
parkinson's disease (pd) is a common neurodegenerative disorder that results from the selective loss of midbrain dopaminergic neurons. |
2007-01-09 |
2023-08-12 |
Not clear |